O. James Sterling - 30 Sep 2024 Form 4 Insider Report for bluebird bio, Inc. (BLUE)

Role
Chief Financial Officer
Signature
/s/ Sydney Gaylin, Attorney-in-Fact
Issuer symbol
BLUE
Transactions as of
30 Sep 2024
Net transactions value
$0
Form type
4
Filing time
02 Oct 2024, 16:06:38 UTC
Previous filing
03 Jul 2024
Next filing
03 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BLUE Common Stock Award $0 +100,000 $0.000000 100,000 30 Sep 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted stock units for common stock vest over a four-year period at the rate of 25% on each of July 1, 2025, July 1, 2026, July 1, 2027 and July 1, 2028.